Analysis model | n | ORr(95%CI) | ORf(95%CI) | Ph | |
---|---|---|---|---|---|
C vs. G | Total analysis | 7 | 0.92 (0.51–1.68) | 1.34 (1.17–1.54) | 0.000 |
 | Hospital-based | 3 | 0.33 (0.12–0.95) | 0.45 (0.34–0.60) | 0.001 |
 | Population-based | 4 | 1.81 (1.22–2.71) | 1.99 (1.69–2.35) | 0.001 |
 | South China | 6 | 0.86 (0.41–1.78) | 1.36 (1.17–1.58) | 0.000 |
 | CP | 6 | 1.24 (0.73–2.11) | 1.54 (1.33–1.78) | 0.000 |
CC vs. GG | Total analysis | 6 | 2.25 (0.64–7.95) | 4.82 (3.30–7.06) | 0.000 |
 | Hospital-based | 2 | 0.58 (0.20–1.70) | 0.55 (0.20–1.54) | 0.441 |
 | Population-based | 4 | 4.47 (1.25–15.95) | 7.01 (4.55–10.78) | 0.000 |
 | South China | 5 | 2.33 (0.53–10.31) | 5.77 (3.78–8.81) | 0.000 |
 | CP | 5 | 3.08 (0.86–1.03) | 5.53 (3.70–8.26) | 0.000 |
CC vs. GG + GC | Total analysis | 6 | 2.50 (0.73–8.52) | 5.31 (3.64–7.74) | 0.000 |
 | Hospital-based | 2 | 0.76 (0.26–2.19) | 0.74 (0.26–2.07) | 0.587 |
 | Population-based | 4 | 4.47 (1.21–16.44) | 7.29 (4.77–11.15) | 0.000 |
 | South China | 5 | 2.69 (0.66–11.05) | 6.47 (4.25–9.88) | 0.000 |
 | CP | 5 | 3.21 (0.90–11.41) | 5.87 (3.95–8.73) | 0.000 |
CC + GC vs. GG | Total analysis | 7 | 0.79 (0.45–1.38) | 1.00 (0.85–1.18) | 0.000 |
 | Hospital-based | 3 | 0.28 (0.09–0.88) | 0.38 (0.27–0.52) | 0.001 |
 | Population-based | 4 | 1.52 (1.24–1.86) | 1.52 (1.24–1.86) | 0.469 |
 | South China | 6 | 0.71 (0.36–1.42) | 0.96 (0.80–1..15) | 0.000 |
 | CP | 6 | 1.08 (0.70–1.65) | 1.18 (0.99–1.40) | 0.000 |